Spasmodic Torticollis (Cervical Dystonia), CCND Winnipeg
MEDICAL THERAPY FOR SPASMODIC TORTICOLLIS
General Information

Overview of Treatments

Medications
Botox®
Injections
Microvascular
Decompression
Surgery

Rhizotomies

Patient Support Groups

Return to the CCND Home
 

     A variety of medications have been tried in the treatment of Spasmodic Torticollis (ST). These include anticholinergics, dopaminergics, and benzodiazepines.

     Drugs in the anticholinergic group include trihexyphenidyl (Artane), biperiden (Akineton), cycrimine (Pagitane) and benztropine (Cogentin). They are usually required in large doses for effective relief of spasms. About half of ST sufferers cannot tolerate the side effects of these medications.

     Dopaminergic drugs include levodopa (Sinemet or Madopar), bromocriptine (Parlodel), and amantadine (Symmetrel). They are only effective in certain cases. The benzodiazepine group includes diazepam (Valium) and flunitrazepam.

     Medications are usually the first line of treatment, because they are the most convenient for the patient, (ie. they cost the least, are easily administered and are the least invasive). Unfortunately, most patients do not find satisfying long-term relief with these drugs, and other forms of treatment are considered.

     Continue to Botox® Injections.

 





Disclaimer

Contact Us


Prepared by A. M. Kaufmann, M. Patel & C. Campbell
© 2001 Centre for Cranial Nerve Disorders, Winnipeg, University of Manitoba, Health Sciences Centre. The information provided on this web-site is intended for educational purposes only, and should not be used to diagnose or treat a disease or disorder. This information is not intended to substitute, supplement, or in any way qualify the services or advice provided by a qualified health care professional. Please consult with a certified health care professional before pursuing any form of medical action. Duplication in any part or form of this document is strictly prohibited. All rights reserved. For further information please read our disclaimer. Web-Site related inquiries can be directed to the Information Provider.